Dennis Paul - Publications

Affiliations: 
1990- Pharmacology and Experimental Therapeutics LSU Health Sciences Center, New Orleans, New Orleans, LA, United States 
Area:
Pain pharmacology, cancer

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Gould HJ, Paul D. Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations. Therapeutics and Clinical Risk Management. 11: 1635-40. PMID 26543371 DOI: 10.2147/TCRM.S81979  1
2015 Ray K, Fahrmann J, Mitchell B, Paul D, King H, Crain C, Cook C, Golovko M, Brose S, Golovko S, Santanam N. Oxidation-sensitive nociception involved in endometriosis-associated pain. Pain. 156: 528-39. PMID 25599233 DOI: 10.1097/01.j.pain.0000460321.72396.88  1
2015 Gould HJ, Paul D. Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy. Pharmacological Research. 91: 99-103. PMID 25301538 DOI: 10.1016/j.phrs.2014.09.006  1
2014 Gould HJ, Soignier RD, Cho SR, Hernandez C, Diamond I, Taylor BK, Paul D. Ranolazine attenuates mechanical allodynia associated with demyelination injury. Pain Medicine (Malden, Mass.). 15: 1771-80. PMID 25132522 DOI: 10.1111/pme.12516  1
2014 Paul D, Soignier RD, Minor L, Tau H, Songu-Mize E, Gould HJ. Regulation and pharmacological blockade of sodium-potassium ATPase: a novel pathway to neuropathy. Journal of the Neurological Sciences. 340: 139-43. PMID 24661409 DOI: 10.1016/j.jns.2014.03.012  1
2013 Kim H, Abd Elmageed ZY, Ju J, Naura AS, Abdel-Mageed AB, Varughese S, Paul D, Alahari S, Catling A, Kim JG, Boulares AH. PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth. Molecular Medicine (Cambridge, Mass.). 19: 253-62. PMID 23821363 DOI: 10.2119/molmed.2011.00001  1
2012 Gould HJ, Casey GP, Paul D. Painful diabetic neuropathy: Current perspective on development and management from bench to bedside-a review Analgesics: New Research. 39-74.  1
2011 Soignier RD, Taylor BK, Baiamonte BA, Lee FA, Paul D, Gould HJ. Measurement of CFA-induced hyperalgesia and morphine-induced analgesia in rats: dorsal vs plantar mechanical stimulation of the hindpaw. Pain Medicine (Malden, Mass.). 12: 451-8. PMID 21332938 DOI: 10.1111/j.1526-4637.2011.01066.x  1
2011 Paul D. Classical models for drug receptor interactions Xpharm: the Comprehensive Pharmacology Reference. 1-4. DOI: 10.1016/B978-008055232-3.60003-0  1
2011 Paul D. Quantitative parameters of drug action Xpharm: the Comprehensive Pharmacology Reference. 1-6. DOI: 10.1016/B978-008055232-3.60002-9  1
2011 Paul D. Drug-receptor interactions Xpharm: the Comprehensive Pharmacology Reference. 1-3. DOI: 10.1016/B978-008055232-3.60001-7  1
2011 Paul D. Experimental designs for the study of receptor-receptor interactions Neuromethods. 60: 305-319. DOI: 10.1007/978-1-61779-179-6_15  1
2010 Casey GP, Paul D, Gould HJ. Insulin is essential for the recovery from allodynia induced by complete Freund's adjuvant. Pain Medicine (Malden, Mass.). 11: 1401-10. PMID 20735747 DOI: 10.1111/j.1526-4637.2010.00936.x  1
2010 Casey GP, Roberts JS, Paul D, Diamond I, Gould HJ. Ranolazine attenuation of CFA-induced mechanical hyperalgesia. Pain Medicine (Malden, Mass.). 11: 119-26. PMID 20447295 DOI: 10.1111/j.1526-4637.2009.00763.x  1
2009 Gould HJ, Garrett C, Donahue RR, Paul D, Diamond I, Taylor BK. Ranolazine attenuates behavioral signs of neuropathic pain. Behavioural Pharmacology. 20: 755-8. PMID 19773645 DOI: 10.1097/FBP.0b013e3283323c90  1
2008 Paul D, Sullivan MA, Weiss RD. Response: providing relief, avoiding euphoria. Addiction Science & Clinical Practice. 4: 26-7. PMID 18497714  1
2007 Flugsrud-Breckenridge MR, Gevirtz C, Paul D, Gould HJ. Medications of abuse in pain management. Current Opinion in Anaesthesiology. 20: 319-24. PMID 17620839 DOI: 10.1097/ACO.0b013e32814b1626  1
2007 Vaccarino AL, Paul D, Mukherjee PK, Rodríguez de Turco EB, Marcheselli VL, Xu L, Trudell ML, Minguez JM, Matía MP, Sunkel C, Alvarez-Builla J, Bazan NG. Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs. Bioorganic & Medicinal Chemistry. 15: 2206-15. PMID 16919959 DOI: 10.1016/j.bmc.2006.07.054  1
2004 Gould HJ, England JD, Soignier RD, Nolan P, Minor LD, Liu ZP, Levinson SR, Paul D. Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat. The Journal of Pain : Official Journal of the American Pain Society. 5: 270-80. PMID 15219259 DOI: 10.1016/j.jpain.2004.04.005  1
2002 Cheng J, Zhang C, Stevens ED, Izenwasser S, Wade D, Chen S, Paul D, Trudell ML. Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes. Journal of Medicinal Chemistry. 45: 3041-7. PMID 12086489 DOI: 10.1021/jm0103561  1
2001 Paul D, Yao D, Zhu P, Minor LD, Garcia MM. 5-Hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: An antisense approach Journal of Pharmacology and Experimental Therapeutics. 298: 674-678. PMID 11454930  1
2000 Gould HJ, Gould TN, England JD, Paul D, Liu ZP, Levinson SR. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Research. 854: 19-29. PMID 10784102 DOI: 10.1016/S0006-8993(99)02216-7  1
2000 Ware TD, Paul D. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments European Journal of Pharmacology. 389: 181-185. PMID 10688982 DOI: 10.1016/S0014-2999(99)00900-0  1
1999 Gould HJ, Gould TN, Paul D, England JD, Liu ZP, Reeb SC, Levinson SR. Development of inflammatory hypersensitivity and augmentation of sodium channels in rat dorsal root ganglia. Brain Research. 824: 296-9. PMID 10196462 DOI: 10.1016/S0006-8993(99)01218-4  1
1998 Gonzales GR, Lewis SA, Amy RN, Weaver MS, Paul D. Tactile illusion-produced number perception in blind and sighted persons Mayo Clinic Proceedings. 73: 1167-1170.  1
1997 Paul D, Gauthier CA, Minor LD, Gonzales GR. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding Life Sciences. 61: 1993-1998. PMID 9366506 DOI: 10.1016/S0024-3205(97)00857-6  1
1996 Gergen KA, Zadina JE, Paul D. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist. European Journal of Pharmacology. 316: 33-8. PMID 8982647 DOI: 10.1016/S0014-2999(96)00656-5  1
1996 Zadina JE, Paul D, Gergen KA, Ge LJ, Hackler L, Kastin AJ. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors. Neuroscience Letters. 215: 65-9. PMID 8880755 DOI: 10.1016/S0304-3940(96)12928-1  1
1996 Gergen KA, Zadina JE, Kastin AJ, Paul D. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors. European Journal of Pharmacology. 298: 235-9. PMID 8846821 DOI: 10.1016/0014-2999(95)00823-3  1
1995 Paul D, Tran JG. Differential cross-tolerance between analgesia produced by α2-adrenoceptor agonists and receptor subtype selective opioid treatments European Journal of Pharmacology. 272: 111-114. PMID 7713142 DOI: 10.1016/0014-2999(94)00695-4  1
1995 Mosaddeghi M, Kapusta DR, Minor LD, Duan N, Paul D. Effects of κ-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney European Journal of Pharmacology: Molecular Pharmacology. 289: 411-417. PMID 7556409 DOI: 10.1016/0922-4106(95)90149-3  1
1994 Paul D, Hornby PJ. Potentiation of intrathecal DAMGO antinociception, but not gastrointestinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade Life Sciences. 56: PL83-PL87. PMID 7823777 DOI: 10.1016/0024-3205(94)00924-4  1
1993 Carr DJJ, Gebhardt BM, Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine- induced suppression of splenocyte natural killer activity Journal of Pharmacology and Experimental Therapeutics. 264: 1179-1186. PMID 8383741  1
1992 Roane DS, Paul D. Evidence of hyperglycemic hyperalgesia by quinpirole. Pharmacology, Biochemistry, and Behavior. 41: 65-7. PMID 1347178 DOI: 10.1016/0091-3057(92)90060-S  1
1992 Tive LA, Pick CG, Paul D, Roques BP, Gacel GA, Pasternak GW. Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist. European Journal of Pharmacology. 216: 249-55. PMID 1327812 DOI: 10.1016/0014-2999(92)90367-D  1
1992 Pick CG, Paul D, Pasternak GW. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. The Journal of Pharmacology and Experimental Therapeutics. 262: 1044-50. PMID 1326621  1
1992 Pick CG, Paul D, Eison MS, Pasternak GW. Potentiation of opioid analgesia by the antidepressant nefazodone. European Journal of Pharmacology. 211: 375-81. PMID 1319913 DOI: 10.1016/0014-2999(92)90395-K  1
1991 Pick CG, Paul D, Pasternak GW. Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life Sciences. 48: 2005-11. PMID 1851915 DOI: 10.1016/0024-3205(91)90155-5  1
1991 Paul D, Pick CG, Tive LA, Pasternak GW. Pharmacological characterization of nalorphine, a kappa 3 analgesic. The Journal of Pharmacology and Experimental Therapeutics. 257: 1-7. PMID 1850462  1
1991 Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, Bodnar RJ. Gender effects and central opioid analgesia. Pain. 45: 87-94. PMID 1677751 DOI: 10.1016/0304-3959(91)90168-W  1
1991 Pick CG, Cheng J, Paul D, Pasternak GW. Genetic influences in opioid analgesic sensitivity in mice. Brain Research. 566: 295-8. PMID 1667610 DOI: 10.1016/0006-8993(91)91712-A  1
1991 Bodnar R, Paul D, Pasternak GW. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus. Brain Research. 558: 224-30. PMID 1664270 DOI: 10.1016/0006-8993(91)90772-N  1
1990 Paul D, Pinel JP. Pirenperone does not attenuate morphine analgesia in spinal rats. Psychopharmacology. 100: 98-101. PMID 2296631 DOI: 10.1007/BF02245797  1
1990 Bodnar RJ, Paul D, Rosenblum M, Liu L, Pasternak GW. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Research. 529: 324-8. PMID 2282501 DOI: 10.1016/0006-8993(90)90845-3  1
1990 Paul D, Levison JA, Howard DH, Pick CG, Hahn EF, Pasternak GW. Naloxone benzoylhydrazone (NalBzoH) analgesia. The Journal of Pharmacology and Experimental Therapeutics. 255: 769-74. PMID 2173757  1
1990 Bodnar RJ, Paul D, Pasternak GW. Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice. Neuropharmacology. 29: 507-10. PMID 2162497 DOI: 10.1016/0028-3908(90)90174-P  1
1990 Paul D, Phillips AG. Associative factors in tolerance to analgesia produced by electrical stimulation in the brainstem. Behavioral Neuroscience. 104: 207-16. PMID 2156521 DOI: 10.1037/h0092462  1
1990 Standifer KM, Paul D, Howard D, Levison J, Pasternak GW. Differential effects of dexamethasone on opioid receptor-mediated analgesia and selective binding New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 31-32.  1
1990 Tive LA, Paul D, Liu L, Pasternak GW. Partial agonist effects of ethylketocyclazocine at supraspinal mu1 receptors New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 57-58.  1
1990 Paul D, Pick CG, Pasternak GW. Dissociation of kappa1 and kappa3 analgesia: Pharmacological characterization of naloxone benzoylhydrazine New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 56.  1
1989 Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 251: 477-83. PMID 2810109  1
1989 Bodnar RJ, Pasternak GW, Mann PE, Paul D, Warren R, Donner DB. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Research. 49: 6280-4. PMID 2804974  1
1989 Kiefel JM, Paul D, Bodnar RJ. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists. Brain Research. 500: 231-40. PMID 2605492 DOI: 10.1016/0006-8993(89)90318-1  1
1989 Ling GS, Paul D, Simantov R, Pasternak GW. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sciences. 45: 1627-36. PMID 2555641 DOI: 10.1016/0024-3205(89)90272-5  1
1989 Paul D, Bodnar RJ, Gistrak MA, Pasternak GW. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. European Journal of Pharmacology. 168: 307-14. PMID 2555205 DOI: 10.1016/0014-2999(89)90792-9  1
1989 Gistrak MA, Paul D, Hahn EF, Pasternak GW. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone. The Journal of Pharmacology and Experimental Therapeutics. 251: 469-76. PMID 2553921  1
1989 Yoburn BC, Paul D, Azimuddin S, Lutfy K, Sierra V. Chronic opioid antagonist treatment increases μ and δ receptor mediated spinal cord opioid analgesia Brain Research. 485: 176-178. PMID 2541864 DOI: 10.1016/0006-8993(89)90680-X  1
1989 Pinel JPJ, Kwon Kim C, Paul DJ, Mana MJ. Contingent tolerance and cross-tolerance to anticonvulsant drug effects: Pentobarbital and ethanol Psychobiology. 17: 165-170. DOI: 10.3758/BF03337832  1
1988 Paul D, Mana MJ, Pfaus JG, Pinel JP. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin. Pharmacology, Biochemistry, and Behavior. 31: 641-7. PMID 3251248 DOI: 10.1016/0091-3057(88)90243-2  1
1988 Paul D, Pasternak GW. Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit. European Journal of Pharmacology. 149: 403-4. PMID 2842168 DOI: 10.1016/0014-2999(88)90680-2  1
1988 Jacobs WJ, Blackburn JR, Buttrick M, Harpur TJ, Kennedy D, Mana MJ, MacDonald MA, McPherson LM, Paul D, Pfaus JG. Observations Psychobiology. 16: 3-19. DOI: 10.3758/BF03327295  1
1986 Paul D, Phillips AG. Selective effects of pirenperone on analgesia produced by morphine or electrical stimulation at sites in the nucleus raphe magnus and periaqueductal gray. Psychopharmacology. 88: 172-6. PMID 3081929 DOI: 10.1007/BF00652235  1
Show low-probability matches.